Hu Y, Zheng S-L, Ye X-L, et al
Some symptoms may take longer to fully clear up
Phase 2 clinical trial data published in the New England Journal of Medicine in 2023 demonstrated substantial mean reductions in body weight in some participants exceeding 20% over 48 weeks alongside improvements in glycaemic control and cardiometabolic markers
After that, tests every 3 to 6 months are common, depending on your health and how the medicine is working for you
They can improve blood pressure, lipid profiles, and endothelial function, which are crucial for a healthy cardiovascular system and reducing cardiovascular risk factors
Preliminary data suggests that this combination is highly effective in promoting weight loss in obese patients with type 2 diabetes in addition to being effective in lowering HbA1c levels [10]